© Reuters. FILE PHOTO: The jar and sryinge are seen in front of the AstraZeneca logo displayed
GENEVA (Reuters) – The COVAX vaccine facility provided nearly 38.4 million doses of COVID-19 vaccine to more than 100 countries and economies across six continents as of Thursday, six weeks after initiation. supplies, a notice said.
Although affected by reduced supply in March and April, and higher demand in India, which produces the majority of main production company AstraZeneca (NASDAQ :), it is expected to deliver dose for all economies required in the first half of 2021 GAVI vaccine alliance and World Health Organization said.
“According to its latest supply forecast, COVAX is expected to deliver at least 2 billion doses of the vaccine by 2021.” Its portfolio, currently based on AstraZeneca and Pfizer (NYSE 🙂 and BioNTech shot, will be diversified.
Fusion Media or anyone associated with Fusion Media will not be liable in any way for loss or damage resulting from dependence on information including data, quotes, charts and buy / sell signals contained in the this site. Please be fully informed about the risks and costs associated with trading the financial markets, which is one of the riskiest investments possible.